In Havas’s second 2015 case study, selected cardiovascular pulse-wave indices deteriorated during RF exposure and improved when a previous-generation Aires device accompanied that exposure. The report provides the measurements for each stage, connecting the environmental question to an observable physiological response.
A connected-device exposure setting
Magda Havas studied a 46-year-old woman on August 20, 2015. She signed the September 5 report with her affiliation in Environmental and Resource Studies at Trent University in Peterborough, Canada. Page 4 identifies American Aires Inc. as the company whose product claims she tested. The report gives no study-level funding statement. See Havas’s signed report and methods. The participant reported headaches associated with wireless devices and described herself as electromagnetically sensitive. She was not taking prescription medication.
The exposure combined a 2.4 GHz cordless-phone base, Wi-Fi router and wireless baby monitor. The study followed four conditions: reference, RF exposure, RF plus the Aires device, and the device with RF switched off. Havas describes blinded assessment in the report. This sequence is distinct from the placebo-device comparison in the first case.
The reported MaxPulse results
The table below reproduces the instrument-index values reported for three cardiovascular measures. These are MaxPulse index readings, not percentages of healing or changes in disease risk.
| Measure | Reference | RF exposure | RF plus Aires device |
|---|---|---|---|
| Differential pulse-wave index (DPI) | 80 | 59 | 82 |
| Eccentric constriction (EC) | 82 | 61 | 86 |
| Arterial elasticity (AE) | 80 | 66 | 84 |
Havas identifies these improvements as the strongest cardiovascular response associated with the Aires device. In the final condition, with RF off and the device still worn, the report also records a reduction in the overall stress score from 51 to 37. Read the original figures and treatment sequence.
What the different instruments measured
MaxPulse recorded pulse-wave indices; Nerve Express assessed orthostatic HRV; other measurements included blood pressure, environmental fields and Bio-Well/GDV outputs. The report describes small HRV changes and no device-associated improvement in heart rate or blood pressure. The positive pulse-wave findings should therefore be identified as pulse-wave findings rather than substituted for a result on every instrument.
Why this belongs in the environmental-health discussion
The laboratory monitored the RF, low-frequency electric and magnetic fields, and other electrical measurements. The Aires device did not produce a measured reduction in those external levels. The reported cardiovascular changes therefore bring the discussion to the biological response—not only the amount of EMF recorded by a field meter.
Aires’ research program follows that question across resonator physics, human physiology and other biological models. This case contributes a specific set of physiological observations from a multi-device exposure setting. It connects naturally to the practical question of how to improve a connected home while keeping technology in use.
Read the originals and continue the investigation
Havas’s second case report and complete measurements · First Havas case and placebo protocol · Cardiovascular and HRV research · Home EMF guide · Aires research and tested technology.
Related source records and guides
- original-source evidence library
- electromagnetic sensitivity and controlled research
- home EMF planning
- cardiovascular research hub
Updated November 5, 2026 · Josh, Aires. Original research and peer reviews remain attributed to their authors and linked above.